IA-1, a new marker for neuroendocrine differentiation in human lung cancer cell lines
- PMID: 8364910
IA-1, a new marker for neuroendocrine differentiation in human lung cancer cell lines
Abstract
IA-1 is a recently isolated novel complementary DNA which encodes a protein of 510 amino acids that contains both a zinc finger DNA-binding domain and a putative prohormone domain. mRNA expression of IA-1 has been found thus far only in tumors of neuroendocrine origin. In this report we describe the expression of IA-1 mRNA in a panel of 64 human lung cancer cell lines. IA-1 mRNA was detected by Northern blot analysis in 97% (30 of 31) of small cell lung cancer cell lines. In contrast, IA-1 mRNA was detected in only 13% (4 of 30) of non-small cell lung cancer cell lines. Nine of the 30 (30%) expressed either chromogranin A mRNA or produced L-dopa decarboxylase. Four of these 9 (44%) had detectable levels of IA-1 mRNA. In most of the lung cancer cell lines examined, IA-1 showed high concordance with the other neuroendocrine markers, L-dopa decarboxylase, and chromogranin A. The one exception was a variant small cell lung cancer cell line which expressed low or nondetectable levels of L-dopa decarboxylase. IA-1 is a candidate marker of neuroendocrine differentiation of human lung tumors.
Similar articles
-
A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines.Cancer Res. 1990 Sep 15;50(18):6068-74. Cancer Res. 1990. PMID: 2168288
-
IA-2, a transmembrane protein tyrosine phosphatase, is expressed in human lung cancer cell lines with neuroendocrine phenotype.Cancer Res. 1996 Jun 15;56(12):2742-4. Cancer Res. 1996. PMID: 8665506
-
Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin.Cancer Res. 1988 Jul 15;48(14):4078-82. Cancer Res. 1988. PMID: 3383200
-
Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.Prostate Suppl. 1998;8:43-51. Prostate Suppl. 1998. PMID: 9690663 Review.
-
Heterogeneity of so-called neuroendocrine lung tumors.Exp Mol Pathol. 2001 Jun;70(3):179-82. doi: 10.1006/exmp.2001.2373. Exp Mol Pathol. 2001. PMID: 11417996 Review.
Cited by
-
Insm1 promotes the transition of olfactory progenitors from apical and proliferative to basal, terminally dividing and neuronogenic.Neural Dev. 2011 Feb 1;6:6. doi: 10.1186/1749-8104-6-6. Neural Dev. 2011. PMID: 21284846 Free PMC article.
-
Ectopic expression of a small cell lung cancer transcription factor, INSM1 impairs alveologenesis in lung development.BMC Pulm Med. 2016 Apr 12;16:49. doi: 10.1186/s12890-016-0215-3. BMC Pulm Med. 2016. PMID: 27072116 Free PMC article.
-
Tumor cells with neuronal intermediate progenitor features define a subgroup of 1p/19q co-deleted anaplastic gliomas.Brain Pathol. 2017 Sep;27(5):567-579. doi: 10.1111/bpa.12434. Epub 2016 Oct 28. Brain Pathol. 2017. PMID: 27543943 Free PMC article.
-
Neurogenin 3 recruits CBP co-activator to facilitate histone H3/H4 acetylation in the target gene INSM1.FEBS Lett. 2007 Mar 6;581(5):949-54. doi: 10.1016/j.febslet.2007.01.087. Epub 2007 Feb 7. FEBS Lett. 2007. PMID: 17300785 Free PMC article.
-
Down-regulation of FXYD3 expression in human lung cancers: its mechanism and potential role in carcinogenesis.Am J Pathol. 2009 Dec;175(6):2646-56. doi: 10.2353/ajpath.2009.080571. Epub 2009 Nov 5. Am J Pathol. 2009. PMID: 19893046 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials